4.2.3 Sodium chlorite approved as a medicinal product
Sodium chlorite has been registered as a medicinal product in the Community Register of Orphan Medicinal Products under the number EU/3 /13/1139 since 19/6/2013. It appears to stop the progression of ALS (amyothrophic lateral sclerosis), according to a study presented.
According to Wikipedia:
“Sodium chlorite interferes with the function of
which form part of the immune system and are involved in inflammatory processes. It is believed that the
amyothrophic lateral sclerosis
(ALS) is associated with overactivation of macrophages, resulting in high levels of
which are responsible for the damage of nerve cells in the brain and spinal cord. In the USA and in the EU sodium chlorite for the treatment of ALS has the status of a
, which provides benefits to pharmaceutical companies in terms of a
I don’t think there’s anything more to add to that.